<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The WAF1 (CIP1/SDI1) gene encodes a cyclin-dependent kinase inhibitor which is induced by <z:mp ids='MP_0002169'>wild-type</z:mp>, but not mutated, p53 gene product </plain></SENT>
<SENT sid="1" pm="."><plain>WAF1 immunohistochemistry has been suggested to clarify the phenotype of overexpressed p53 gene product </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated both p53 and WAF1 gene products by immunohistochemistry in 98 esophagectomy specimens with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> and/or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus and esophagogastric junction </plain></SENT>
<SENT sid="3" pm="."><plain>Diffuse positive p53 staining was found in 40 of 88 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (45%) and in dysplastic <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> in 20 of 65 cases (31%), but not in Barrett mucosa without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 36, P = .0004) </plain></SENT>
<SENT sid="4" pm="."><plain>Eighty-eight percent of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> exhibited WAF1 expression, but there was no association with p53 and WAF1 staining </plain></SENT>
<SENT sid="5" pm="."><plain>WAF1 protein was also identified in <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> and in esophageal squamous and gastric epithelium </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast to <z:mp ids='MP_0002038'>carcinomas</z:mp>, a unique pattern of mutually exclusive p53 and WAF1 expression was found in five cases of dysplastic <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e>; a missense mutation at codon 175 of p53 was identified in one </plain></SENT>
<SENT sid="7" pm="."><plain>p53 staining of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> was associated with shorter patient survival but was not independent of stage; WAF1 status added no prognostic information </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings show that WAF1 immunohistochemistry complements p53 immunohistochemistry in some cases of Barrett <z:mpath ids='MPATH_589'>dysplasia</z:mpath> but not in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Positive p53 immunostaining can serve to confirm a neoplastic process in Barrett mucosa </plain></SENT>
<SENT sid="10" pm="."><plain>Positive staining of <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> may be an indication of advanced stage </plain></SENT>
</text></document>